• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A cross-sectional evaluation of the idiopathic pulmonary fibrosis patient satisfaction and quality of life with a care coordinator.对特发性肺纤维化患者在护理协调员协助下的满意度和生活质量进行的横断面评估。
J Thorac Dis. 2019 Dec;11(12):5547-5556. doi: 10.21037/jtd.2019.11.41.
2
The Burden of Illness of Idiopathic Pulmonary Fibrosis: A Comprehensive Evidence Review.特发性肺纤维化的疾病负担:全面的证据综述。
Pharmacoeconomics. 2018 Jul;36(7):779-807. doi: 10.1007/s40273-018-0631-8.
3
Health Care Costs at the End of Life for Patients with Idiopathic Pulmonary Fibrosis. Evaluation of a Pilot Multidisciplinary Collaborative Interstitial Lung Disease Clinic.特发性肺纤维化患者生命末期的医疗费用。试点多学科协作性间质性肺疾病临床诊疗中心的评估。
Ann Am Thorac Soc. 2020 Jun;17(6):706-713. doi: 10.1513/AnnalsATS.201909-707OC.
4
IPF Care: a support program for patients with idiopathic pulmonary fibrosis treated with pirfenidone in Europe.IPF关爱:欧洲一项针对使用吡非尼酮治疗的特发性肺纤维化患者的支持项目。
Adv Ther. 2015 Feb;32(2):87-107. doi: 10.1007/s12325-015-0183-7. Epub 2015 Feb 18.
5
Health care utilization and costs of idiopathic pulmonary fibrosis in U.S. Medicare beneficiaries aged 65 years and older.美国65岁及以上医疗保险受益人中特发性肺纤维化的医疗保健利用情况及费用
Ann Am Thorac Soc. 2015 Jul;12(7):981-7. doi: 10.1513/AnnalsATS.201412-553OC.
6
Qualitative European survey of patients with idiopathic pulmonary fibrosis: patients' perspectives of the disease and treatment.欧洲特发性肺纤维化患者定性调查:患者对该疾病及治疗的看法
BMC Pulm Med. 2016 Jan 14;16:10. doi: 10.1186/s12890-016-0171-y.
7
Management and attitudes about IPF (Idiopathic Pulmonary Fibrosis) among physicians from Latin America.拉丁美洲医生对特发性肺纤维化(IPF)的管理和态度。
BMC Pulm Med. 2018 Jan 10;18(1):5. doi: 10.1186/s12890-017-0569-1.
8
Idiopathic Pulmonary Fibrosis: Utilization of Health Services and Out-Of-Pocket Health Expenditures in Greece.特发性肺纤维化:希腊的卫生服务利用和自付卫生支出。
Value Health Reg Issues. 2020 Sep;22:44-48. doi: 10.1016/j.vhri.2020.04.002. Epub 2020 Aug 7.
9
Patient expectations and experiences in idiopathic pulmonary fibrosis: implications of patient surveys for improved care.特发性肺纤维化患者的期望和体验:患者调查对改善护理的启示。
Expert Rev Respir Med. 2014 Apr;8(2):173-8. doi: 10.1586/17476348.2014.880056. Epub 2014 Jan 22.
10
Treatment patterns, resource use and costs of idiopathic pulmonary fibrosis in Spain--results of a Delphi Panel.西班牙特发性肺纤维化的治疗模式、资源利用及成本——德尔菲小组的结果
BMC Pulm Med. 2016 Jan 12;16:7. doi: 10.1186/s12890-016-0168-6.

引用本文的文献

1
Innovative approaches to managing chronic multimorbidity: A multidisciplinary perspective.慢性多重疾病管理的创新方法:多学科视角
World J Clin Cases. 2025 Jul 6;13(19):102484. doi: 10.12998/wjcc.v13.i19.102484.
2
Real World Experience: Impact of a Specialist Interstitial Lung Disease Nurse on Health Care Utilization.真实世界经验:间质性肺病专科护士对医疗保健利用的影响。
Open Respir Arch. 2025 Jan 18;7(2):100400. doi: 10.1016/j.opresp.2025.100400. eCollection 2025 Apr-Jun.
3
Patient satisfaction impact indicators from a psychosocial perspective.从社会心理角度看患者满意度的影响因素。
Front Public Health. 2023 Feb 22;11:1103819. doi: 10.3389/fpubh.2023.1103819. eCollection 2023.
4
Care programs and their components for patients with idiopathic pulmonary fibrosis: a systematic review.特发性肺纤维化患者的护理方案及其组成部分:系统评价。
Respir Res. 2021 Aug 16;22(1):229. doi: 10.1186/s12931-021-01815-8.
5
Idiopathic pulmonary fibrosis management: caring is sparing.特发性肺纤维化的管理:关爱即节省。
J Thorac Dis. 2020 Oct;12(10):5265-5268. doi: 10.21037/jtd.2020.04.44.
6
Ligustilide modulates oxidative stress, apoptosis, and immunity to avoid pathological damages in bleomycin induced pulmonary fibrosis rats via inactivating TLR4/MyD88/NF-KB P65.藁本内酯通过使TLR4/MyD88/NF-κB P65失活来调节氧化应激、细胞凋亡和免疫,以避免博来霉素诱导的肺纤维化大鼠出现病理损伤。
Ann Transl Med. 2020 Aug;8(15):931. doi: 10.21037/atm-20-4233.
7
Beyond standard care?-idiopathic pulmonary fibrosis patients' perception of care coordinators.超越标准护理?——特发性肺纤维化患者对护理协调员的看法。
J Thorac Dis. 2020 Aug;12(8):3930-3933. doi: 10.21037/jtd.2020.04.40.

本文引用的文献

1
Best supportive care for idiopathic pulmonary fibrosis: current gaps and future directions.特发性肺纤维化的最佳支持性治疗:当前的差距和未来的方向。
Eur Respir Rev. 2018 Feb 7;27(147). doi: 10.1183/16000617.0076-2017. Print 2018 Mar 31.
2
Improving Heart Failure Outcomes: The Role of the Clinical Nurse Specialist.改善心力衰竭治疗结果:临床护理专家的作用
Crit Care Nurs Q. 2016 Oct-Dec;39(4):335-44. doi: 10.1097/CNQ.0000000000000127.
3
The Interdisciplinary Management of Brain Metastases.脑转移瘤的多学科管理
Dtsch Arztebl Int. 2016 Jun 17;113(24):415-21. doi: 10.3238/arztebl.2016.0415.
4
Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada.加拿大全国数据中特发性肺纤维化的流行病学和生存情况。
Eur Respir J. 2016 Jul;48(1):187-95. doi: 10.1183/13993003.01504-2015. Epub 2016 May 26.
5
Psychometric Properties of the Patients' Satisfaction Instrument FAMCARE-P13 in a Palliative Care Unit.姑息治疗病房中患者满意度量表FAMCARE-P13的心理测量学特性
Am J Hosp Palliat Care. 2017 Aug;34(7):597-602. doi: 10.1177/1049909116645511. Epub 2016 Apr 21.
6
The Italian version of the FAMCARE scale: a validation study.FAMCARE量表的意大利语版本:一项效度研究。
Support Care Cancer. 2016 Sep;24(9):3821-30. doi: 10.1007/s00520-016-3187-1. Epub 2016 Apr 11.
7
Qualitative European survey of patients with idiopathic pulmonary fibrosis: patients' perspectives of the disease and treatment.欧洲特发性肺纤维化患者定性调查:患者对该疾病及治疗的看法
BMC Pulm Med. 2016 Jan 14;16:10. doi: 10.1186/s12890-016-0171-y.
8
Multidisciplinary Intervention in Patients with Musculoskeletal Pain: a Randomized Clinical Trial.肌肉骨骼疼痛患者的多学科干预:一项随机临床试验。
Int J Behav Med. 2016 Feb;23(1):1-11. doi: 10.1007/s12529-015-9486-y.
9
IPF Care: a support program for patients with idiopathic pulmonary fibrosis treated with pirfenidone in Europe.IPF关爱:欧洲一项针对使用吡非尼酮治疗的特发性肺纤维化患者的支持项目。
Adv Ther. 2015 Feb;32(2):87-107. doi: 10.1007/s12325-015-0183-7. Epub 2015 Feb 18.
10
Perceptions, experiences and needs of patients with idiopathic pulmonary fibrosis.特发性肺纤维化患者的认知、经历与需求
J Adv Nurs. 2015 May;71(5):1055-65. doi: 10.1111/jan.12587. Epub 2014 Dec 23.

对特发性肺纤维化患者在护理协调员协助下的满意度和生活质量进行的横断面评估。

A cross-sectional evaluation of the idiopathic pulmonary fibrosis patient satisfaction and quality of life with a care coordinator.

作者信息

Hambly Nathan, Goodwin Sarah, Aziz-Ur-Rehman Afia, Makhdami Nima, Ainslie-Garcia Margaret, Grima Daniel, Cox Gerard, Kolb Martin, Fung Diana, Cabalteja Czerysh, DeMarco Patricia, Moldaver Daniel

机构信息

Firestone Institute for Respiratory Health, St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.

Division of Respirology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

出版信息

J Thorac Dis. 2019 Dec;11(12):5547-5556. doi: 10.21037/jtd.2019.11.41.

DOI:10.21037/jtd.2019.11.41
PMID:32030274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6988068/
Abstract

BACKGROUND

Canadian and international guidelines recommend specialized, multidisciplinary teams for the treatment of patients with idiopathic pulmonary fibrosis (IPF). The objective of this cross-sectional clinical study was to investigate the effect of a care coordinator on IPF patient satisfaction and quality of life.

METHODS

Forty IPF patients were enrolled from the practices of two physicians (n=20/physician), with either low (LCU) or high-coordinator use (HCU). Patient satisfaction was measured with modified FAMCARE and IPF Care UK Patient Support Program (UK-CARE) surveys. Health related quality of life (HRQoL) was assessed with the living with IPF impacts (L-IPFi) survey. An economic model assessed the impact of the coordinator; staff surveys informed patient management requirements, and costs were derived from published literature.

RESULTS

Patient satisfaction was similar between the clinics; a trend (P=0.1) towards increased satisfaction among HCU patients was observed. Patients in the HCU clinic reported increased satisfaction (P<0.05) with their current care compared with care prior to joining the tertiary-care clinic, while LCU patients did not. IPF patient HRQoL did not differ between clinics. The coordinator was estimated to alleviate approximately 30% of a physician's IPF-related work load, and to facilitate the care of more patients per physician. Modelled estimates suggest the coordinator lead to annual cost-savings of $137,212.

CONCLUSIONS

Reliance upon a coordinator during routine management of IPF patients may improve patient satisfaction, spare physician time and lead to annual cost-savings. Future studies should examine the impact of a coordinator on healthcare resource utilization.

摘要

背景

加拿大及国际指南推荐采用专业的多学科团队来治疗特发性肺纤维化(IPF)患者。这项横断面临床研究的目的是调查护理协调员对IPF患者满意度和生活质量的影响。

方法

从两位医生的诊所招募了40名IPF患者(每位医生各20名),这些患者分为低协调员使用组(LCU)和高协调员使用组(HCU)。通过改良的FAMCARE和英国IPF护理患者支持计划(UK-CARE)调查来测量患者满意度。采用IPF生活影响(L-IPFi)调查评估健康相关生活质量(HRQoL)。一个经济模型评估了协调员的影响;员工调查为患者管理要求提供了信息,成本则来自已发表的文献。

结果

两个诊所的患者满意度相似;观察到HCU组患者的满意度有上升趋势(P=0.1)。与加入三级护理诊所之前接受的护理相比,HCU诊所的患者对当前护理的满意度有所提高(P<0.05),而LCU组患者则没有。两个诊所的IPF患者HRQoL没有差异。据估计,协调员可减轻医生约30%的IPF相关工作量,并使每位医生能够护理更多患者。模型估计表明,协调员可实现每年节省成本137,212美元。

结论

在IPF患者的常规管理中依赖协调员可能会提高患者满意度、节省医生时间并实现年度成本节约。未来的研究应考察协调员对医疗资源利用的影响。